A major study reveals that GLP-1 drugs like Ozempic offer significant health benefits, including reduced risks of Alzheimer’s disease, seizures, and addiction-related issues. However, the research also highlights potential side effects such as gastrointestinal problems and kidney issues. Researchers found that these drugs can lower the risk of suicidal ideation, self-harm, and obesity-related conditions. Despite the benefits, doctors must weigh the risks carefully and consider nutritional education for patients with gastrointestinal issues or those trying to quit smoking or drinking.
The study, involving over two million veterans, compares health outcomes between those using GLP-1 medications and those not. The findings suggest that these drugs could be particularly useful for weight loss and quitting smoking or drinking while improving overall health. However, healthcare providers should only recommend these medications to individuals who can handle potential side effects.
Ozempic, approved for type 2 diabetes and cardiovascular benefits, is now being explored for additional uses, but patient safety remains a top priority for manufacturers like Novo Nordisk.
For more insights into health trends and treatments, visit www.foxnews.com/health.
Source: https://www.foxnews.com/health/ozempics-health-benefits-keep-growing-risks-worth-it